Grundinformationen
- Standard-SMILES
O=P(O)(O)OC[C@H]1O[C@@](O)(COP(=O)(O)O)[C@@H](O)[C@@H]1O- InChIKey
RNBGYGVWRKECFJ-ZXXMMSQZSA-N- Summenformel
- C6H14O12P2
- Durchschnittliche Molmasse
- 340,12 g/mol
Überblick
Alpha-D-fructofuranose 1,6-bisphosphate is a D-fructofuranose 1,6-bisphosphate with an alpha-configuration at the anomeric position. It is functionally related to an alpha-D-fructofuranose. It is a conjugate acid of an alpha-D-fructofuranose 1,6-bisphosphate(4-).
Namen und Bezeichner
- Bevorzugter Name
- Fructose-1,6-Diphosphate
- IUPAC
- [(2S,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate
Namen und Synonyme
fructose-1,6-diphosphateFructose 1,6-diphosphate[(2S,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate((2S,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl)methyl dihydrogen phosphateSr-FDPRefChem:600595GlyTouCan:G18745STstrontium fructose-1,6-diphosphateG18745STANW5CM3PJ7alpha-D-FosfructofuranoseUNII-ANW5CM3PJ7
Weitere Namen anzeigen
NSC-575531,6-di-O-phosphono-alpha-D-fructofuranoseCHEMBL1089962alpha-D-Fructofuranose 1,6-diphosphatealpha-D-fructofuranose 1,6-bisphosphatealpha-D-Fructofuranose, 1,6-bis(dihydrogen phosphate)fructose-1,6-bisphosphateAFP
Datenbank-Bezeichner
- CAS
34693-23-7- PubChem CID
- 445557
- ChEMBL
CHEMBL1089962- ChEBI
CHEBI:40595- UNII
- ANW5CM3PJ7
- Nikkaji
- J792.775D
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- -5,6
- Polarare Oberfläche (TPSA)
- 203 Ų
- H-Brücken-Donoren
- 7
- H-Brücken-Akzeptoren
- 12
- Frei drehbare Bindungen
- 6
- Schwere Atome
- 20
- Formalladung
- 0
- Komplexität
- 428
Experimentelle und physikochemische Eigenschaften
Collision Cross Section168.2 Ų [M+Na]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]
Chemie und Industrie
Pharmakologische Informationen
ATC Code
C - Cardiovascular system
QC - Cardiovascular system
MeSH Pharmacological Classification
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume.
Biologically active substances whose activities affect or play a role in the functioning of the immune system.
Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids.
Zugehörige Reaktionen
3
Verknüpfte Notizen
Wird geladen…